REFERENCES
- Walid M A. Pharmacodynamic monitoring of cyclosporin. Clin Pharmacokinet. 1992; 23(6)428–448
- Fahr A. Cyclosporin clinical pharmacokinetics. Clin Pharmacokinet. 1993; 24(6)472–495, [PUBMED], [INFOTRIEVE]
- Faulds D, Goa K L, Benfield P. Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunregulatory disorders. Drugs. 1993, 6: 953–1040
- Akagi H, Reynolds A, Hjelm M. Cyclosporin A and its metabolites, distribution in blood and tissues. J Int Med Res. 1991; 1(9)1–18
- Gijtenbeek J M, van den Bent M J, Vecht C J. Cyclosporine neurotoxicity: a review. J Neurol. 1999; 246(5)339–346, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Hauben M. Cyclosporin neurotoxicity. Pharmacotherapy 1996; 16(4)576–583, [PUBMED], [INFOTRIEVE], [CSA]
- Bartynski W S, Zeigler Z, Spearman M P, Lin L, Shadduck R K, Lister J. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. Am J Neuroradiol. 2001; 22: 1901–1914, [PUBMED], [INFOTRIEVE], [CSA]
- Trullemans F, Grignard F, Van Camp B, Schots R. Clinical findings and magnetic resonance imaging in severe cyclosporin-related neurotoxicity after allogeneic bone marrow transplantation. Eur J Haematol. 2001; 67: 94–99, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Reece D E, Frei-Lahr D A, Shepherd J D, Dorovoni-Zis K, Gascoyne R D, Graeb D A, Spinell J J, Barnett M J, Klingemann H G, Herzig G P, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant. 1991; 8(5)393–401, [PUBMED], [INFOTRIEVE]
- Apsner R, Schulenburg A, Steinhoff N, Keil F, Janata K, Kalhs P, Greinix H. Cyclosporin A-induced ocular flutter after marrow transplantation. Bone Marrow Transplant. 1997; 20: 255–256, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Openshaw H. Eye movement abnormality associated with cyclosporin. J Neurol Neurosurg Psychiatry. 2001; 70: 809, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Openshaw H, Slatkin N E, Smith E. Eye movement disorders in bone marrow transplant patients on cyclosporin and ganciclovir. Bone Marrow Transplant. 1997; 19: 503–505, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Schon F, Hodgson T L, Mort D, Kennard C. Ocular flutter associated with a localized lesion in the paramedian pontine reticular formation. Ann Neurol. 2001; 50(3)413–416, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Zee D S, Robinson D A. A hypothetical explanation of saccadic oscillations. Ann Neurol. 1979; 5: 405–414, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Versino M, Mascolo A, Piccolo G, Alloni R, Cosi V. Opsoclonus in a patient with cerebellar dysfunction. J Neuro-Ophthalmol. 1999; 19(4)229–231, [CSA]
- Ellenberger C, Jr, Campa J F, Netsky M G. Opsoclonus and parenchymatous degeneration of the cerebellum. The cerebellar origin of an abnormal ocular movement. Neurology. 1968; 18(11)1041–1046, [PUBMED], [INFOTRIEVE]
- Ridley A, Kennard C, Scholtz C L, Buttner-Ennever J A, Summers B, Turnball A. Omnipause neurons in two cases of opsoclonus associated with oat cell carcinoma of the lung. Brain. 1987; 110(Pt 6)1699–1709, [PUBMED], [INFOTRIEVE]